FDA Determines Regulatory Review Period for Tack Endovascular System Patent Extension

Summary

The US Food and Drug Administration has published a notice determining the regulatory review period for patent extension of the Tack Endovascular System (6F), following submissions to the US Patent and Trademark Office.